期刊文献+

急性白血病患者感染的临床特点和经验性抗感染治疗 被引量:5

原文传递
导出
摘要 感染是急性白血病患者常见并发症,也是主要死亡原因之一。随着高强度化疗方案的推广,包括抗感染措施在内的支持治疗对保障化疗安全进行,提高急性白血病患者疗效尤为重要。我们回顾性总结急性白血病患者感染的临床特点,重点对致病菌的菌群分布及药敏特征、经验性抗感染治疗方案的选择及其疗效进行了分析。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2008年第3期204-207,共4页 Chinese Journal of Hematology
  • 相关文献

参考文献12

  • 1Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis, 2002, 34: 730-751.
  • 2Guven GS, Uzun O, Cakir B, et al. Infectious complications in patients with hematological malignancies consulted by the Infectious Diseases team: a retrospective cohort study (1997-2001). Support Care Cancer, 2006, 14: 52-55.
  • 3Girmenia C, LoCocol F, Breccia M, et al. Infectious complications in patients with acute promyelocytic leukemia treated with the AIDA regimen. Leukemia, 2003, 17: 925-930.
  • 4文细毛,任南,吴安华,徐秀华,李洁.白血病患者医院感染1 310株病原菌分布及耐药性分析[J].中华医院感染学杂志,2005,15(1):96-99. 被引量:12
  • 5周绪华,梁新亮,李轶,周在咸.临床常见病原菌分布及耐药性分析[J].实用诊断与治疗杂志,2004,18(2):120-121. 被引量:151
  • 6黄敏,孙自镛,朱旭慧,张义成,刘文励,周剑峰.血液病房分离280株病原菌及其耐药性分析[J].中国感染与化疗杂志,2006,6(3):178-181. 被引量:11
  • 7朱德妹,汪复,张婴元.2003年上海地区细菌耐药性监测[J].中国抗感染化疗杂志,2005,5(1):4-12. 被引量:147
  • 8何学贤,王显扬.血培养3 250份标本结果分析[J].中华医学检验杂志,1999,22(2):96-97. 被引量:28
  • 9Edmond MB, Wallace SE, McClish DK, et al. Nosocomial blood-stream infection in United States hospital: a three-year analysis. Clin Infect Dis, 1999, 29:239-244.
  • 10Velasco E, Byington R, Martins CA, et al. Prospective evaluation of the epidemiology, microbiology, and outcome of blood- stream infections in hematologic patients in a single cancer center. Eur J Clin Microbiol Infect Dis, 2003, 22: 137-143.

二级参考文献52

  • 1朱德妹,汪复,胡付品,吴湜,张婴元.2002年上海地区医院细菌耐药性监测[J].中华传染病杂志,2004,22(3):154-159. 被引量:63
  • 2申正义,孙自镛,王洪波.湖北地区临床分离菌耐药性监测[J].中国抗感染化疗杂志,2004,4(5):263-267. 被引量:36
  • 3熊自忠,朱德妹,汪复,张婴元.CTX-M-14和CTX-M-24编码基因的检测及其功能表达[J].中华医学杂志,2004,84(17):1454-1459. 被引量:15
  • 4叶芳,高芳,乔振华,苏丽萍,杨承玉,卢素琴,卢玲玲.血液病合并感染的临床特征分析及防治措施探讨[J].临床医药实践,2003,12(2):96-98. 被引量:9
  • 5[1]Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer[J]. Clin Infect Dis, 2002, 34:730-751
  • 6[4]Hathorn JW, Lyke K. Empirical treatment of febrile neutropenia: evolution of current therapeutic approachcs[J]. Clin Infect Dis, 1997, 24 (Suppl2): S256-265
  • 7[5]Cometta A, Glauser MP. Empiric antibiotic nonotherapy with carbapenemsin febrile neutropenia: a review[J]. J Chemother,1996, 8:375-381
  • 8[6]Shah PM, Heller A, Fuhr HG, et al. Empirical monotherapy with meropenem versus imipenem/cilastatin for febrile episodes in neutropenic patients[J]. Infection 1996, 24:480-484
  • 9[7]Norrby SR, Gildon KM. Safety profile of meropcnem: a review of nearly 5 ,000 patients treated withmeropenem[J]. ScandJ In feet Dis, 1999, 31:3-10
  • 10[9]Vandercam B, Gerain J, Humblet Y, et al. Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients[J]. Ann Hematol, 2000, 79:152-157

共引文献344

同被引文献20

  • 1Dellinger RP,Levy MM,Carlet JM,et al.Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock:2008.Crit Care Med,2008,36:296.
  • 2Rivers E,Nguyen B,Havstad S,et al.Early goal-directed therapy in the treatment of severe sepsis and septic shock.N Engl J Med,2001,345:1368.
  • 3Benchekrounc S,Karpati PC,Berton C,et al.Diastolic arterial blood pressure:a reliable early predictor of survival in human septic shock.J Trauma,2008,64:1188.
  • 4Dellinger RP,Levy MM,Carlet JM,et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock : 2008. Crit Care Med, 2008,36 ( 1 ) : 296- 327.
  • 5AL-Tonbary YA,Soliman OE,Sarhan MM,et al. Nosocomial infections and fever of unknown origin in pediatric hematology/oncology unit:a retrospective annual study. World J Pediatics, 2011,7( 1 ) : 60-64.
  • 6Jahan A. Septic shock in the postoperative patient: three important management decisions. Cleve Clin J Med, 2006,73 Suppl 1 :S67- 71.
  • 7Annane D,Bellissant E, Bollaert PE,et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults. TAMA, 2009,301 ( 22 ): 2362-2375.
  • 8Yarema TC, Yost S. Low-dose corticosteroids to treat septic shock: a critical literature review. Crit Care Nurse, 2011,31 (6) : 16-26.
  • 9王坚敏,汤静燕,薛惠良,潘慈,陈静,周敏,董璐,顾龙君.儿童恶性肿瘤化疗后合并感染的病原菌及抗生素应用探讨[J].中华血液学杂志,2009,30(1):61-63. 被引量:8
  • 10邱莹玉,高凌霞,刘翠英.伊曲康唑治疗28例恶性血液病合并侵袭性真菌感染的临床分析[J].中国当代医药,2009,16(5):121-122. 被引量:3

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部